[XENE] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
06-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -84.37%
YoY- -85.78%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 0 0 6,000 0 0 0 16 -
PBT -10,036 -11,304 -8,558 -14,383 -7,801 -3,755 -8,065 15.73%
Tax -29 37 357 678 200 159 14 -
NP -10,007 -11,341 -8,558 -14,383 -7,801 -3,755 -8,065 15.51%
Tax Rate - - - - - - - -
Total Cost 10,007 11,341 14,558 14,383 7,801 3,755 8,081 15.36%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin 0.00 0.00 -142.63 0.00 0.00 0.00 -50,406.25 -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -0.39 -0.44 -0.34 -0.71 -0.55 -0.22 -0.45 -9.12%
EPS Diluted -0.39 -0.44 -0.33 -0.71 -0.55 -0.21 -0.45 -9.12%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.